Sarissa Capital urges Alkermes shareholders to vote for its board nominees after years of rejections
After overhauling Amarin’s board earlier this year, activist investor Sarissa Capital has set its sights on Alkermes. In a new letter to shareholders, the group is pressing Alkermes investors to vote ...
Shareholders in Alkermes have quelled a challenge from Sarissa Capital, reelecting seven board members and rejecting three nominees from the activist investor, the Ireland-based drugmaker said. Early ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
GREENWICH, Conn.--(BUSINESS WIRE)-- Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa believes Amarin’s stock is ...
Sarissa believes Amarin leadership will continue to destroy shareholder value during this critical period; We cannot afford to maintain the status quo Sarissa has a stellar track record of success and ...
GREENWICH, Conn.--(BUSINESS WIRE)--Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Sarissa Capital is outraged but not ...
Amarin Corporation and Sarissa Capital Management, the company’s largest shareholder, have engaged in a public war of words this month over a recent board refreshment process. Amarin, a New ...
On Tuesday, Sarissa Capital Management, an activist investment firm focusing on the pharmaceutical sector, put pressure on Amarin (US:AMRN) to hold a special meeting to straighten out its board issues ...
We are long-term Alkermes shareholders owning over $400 million in stock who believe that the company is significantly undervalued and not run optimally. For this reason, over the last several years, ...
(Reuters) - Activist hedge fund Sarissa Capital Management LP said on Wednesday that U.S. respiratory drug company Innoviva Inc reneged on a proxy settlement deal that was struck earlier in the day.
(Reuters) - U.S. respiratory drug company Innoviva Inc has reached a settlement with activist hedge fund Sarissa Capital Management LP to replace its board of directors and remove the threat of a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results